These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Selumetinib increases the efficacy of first-line dacarbazine.
    Journal: Cancer Discov; 2013 Jul; 3(7):OF16. PubMed ID: 23847359.
    Abstract:
    Selumetinib plus dacarbazine prolongs progression-free survival in BRAF-mutant melanoma.
    [Abstract] [Full Text] [Related] [New Search]